Buscar Búsqueda de estructuras
wx_img
Inquiry Form
  1. Home
  2. Cerdulatinib

Cerdulatinib

Cerdulatinib is a small molecule SYK/JAK kinase inhibitor in development for treatment of hematological malignancies. It has lowest nM IC50 values against TYK2, JAK1, JAK2, JAK3, FMS, and SYK. Cerdulatinib is a reversible ATP-competitive dual JAK and Syk inhibitor. The FDA granted orphan drug status to cerdulatinib for the treatment of peripheral T-cell lymphoma (PTCL).

ethyl 4-chloro-2-(methylsulfanyl)pyrimidine-5-carboxylate
ethyl 4-chloro-2-(methylsulfanyl)pyrimidine-5-carboxylate
CM108263
5909-24-0
ethyl 4-(cyclopropylamino)-2-(methylthio)pyrimidine-5-carboxylate
ethyl 4-(cyclopropylamino)-2-(methylthio)pyrimidine-5-carboxylate
CM363238
651734-65-5
2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid
2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid
CM104193
23945-44-0
4-[4-(ethanesulfonyl)piperazin-1-yl]aniline
4-[4-(ethanesulfonyl)piperazin-1-yl]aniline
CM578067
611400-14-7
2,4-dichloropyrimidine-5-carbonyl chloride
2,4-dichloropyrimidine-5-carbonyl chloride
CM100730
2972-52-3
2,4-Dichloropyrimidine-5-carboxamide
2,4-Dichloropyrimidine-5-carboxamide
CM167387
1240390-28-6